Erin M. Tricker, Ph.D. - Publications
Affiliations: | 2011 | University of California, Los Angeles, Los Angeles, CA |
Area:
Molecular Biology, Cell BiologyYear | Citation | Score | |||
---|---|---|---|---|---|
2015 | Tanizaki J, Ercan D, Capelletti M, Dodge ME, Xu C, Bahcall M, Tricker EM, Butaney M, Calles A, Sholl LM, Hammerman PS, Oxnard GR, Wong KK, Janne PA. Identification of oncogenic and drug-sensitizing mutations in the extracellular domain of FGFR2. Cancer Research. PMID 26048680 DOI: 10.1158/0008-5472.Can-14-3771 | 0.534 | |||
2015 | Tricker EM, Xu C, Uddin S, Capelletti M, Ercan D, Ogino A, Pratilas CA, Rosen N, Gray NS, Wong KK, Janne PA. Combined EGFR/MEK Inhibition Prevents the Emergence of Resistance in EGFR mutant Lung Cancer. Cancer Discovery. PMID 26036643 DOI: 10.1158/2159-8290.Cd-15-0063 | 0.456 | |||
2015 | Tricker EM, Xu C, Wong K, Janne PA. Abstract 2595: Efficacy of cetuximab and mutant selective EGFR inhibitor WZ4002 in EGFR T790M and non-T790M models of erlotinib resistant non-small cell lung cancer Cancer Research. 75: 2595-2595. DOI: 10.1158/1538-7445.Am2015-2595 | 0.411 | |||
2014 | Tricker EM, Xu C, Ercan D, Ogino A, Wong K, Janne P. Abstract 1832: Combined EGFR and MEK inhibition prevents the emergence of drug resistance in EGFR mutant non-small cell lung cancer (NSCLC) Cancer Research. 74: 1832-1832. DOI: 10.1158/1538-7445.Am2014-1832 | 0.438 | |||
2008 | Tricker E, Cheng G. With a little help from my friends: modulation of phagocytosis through TLR activation. Cell Research. 18: 711-2. PMID 18596701 DOI: 10.1038/Cr.2008.78 | 0.413 | |||
Show low-probability matches. |